Molecular basis of COVID-19,ARDS and COVID-19-associated ARDS:Diagnosis pathogenesis and therapeutic strategies
作者机构:Biopharmaceutical Research LabAnusandhan Kendra-1SASTRA Deemed-to-be UniversityThanjavur613401India School of Chemical and BiotechnologySASTRA Deemed-to-be UniversityThanjavur613401India
出 版 物:《BIOCELL》 (生物细胞(英文))
年 卷 期:2023年第47卷第11期
页 面:2335-2350页
核心收录:
学科分类:0710[理学-生物学] 1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:SASTRA Deemed-to-be University Tamil Nadu India
主 题:ARDS SARS-CoV-2 Variants Pathogenesis Risk factors Vaccines
摘 要:The novel coronavirus pneumonia(COVID-19)is spreading worldwide and threatening people *** routes by which SARS-CoV-2 causes lung injury have grown to be a major concern in the scientific community since patients with new Coronavirus,severe acute respiratory syndrome coronavirus(SARS-CoV-2)have a high likelihood of developing acute respiratory distress syndrome(ARDS)in severe *** mortality rate of COVID-19 has increased over the period due to rapid spread,and it becomes crucial to understand the disease epidemiology,pathogenic mechanisms,and suitable treatment *** is a respiratory disorder and is one of the clinical manifestations observed in patients with severe *** this scenario,it is important to address this problem to develop suitable treatment *** review attempts to present the prevalence of ARDS in COVID-19 patients and their predictive causes and risk factors,highlighting the contrasting features of COVID-19-induced ARDS with typical *** review also presents insights into the association between SARS-CoV-2 and lung damage while exploring the potential COVID-19 mechanisms in ARDS from the perspective of the angiotensin-converting enzyme 2 protein,cytokine storm,immune responses,and other signaling *** review also discusses the diagnosis strategies,pathogenesis,risk factors,and treatment options of COVID-19-related ARDS.